FDA Adverse Event Death Summary report: N

AFX SYSTEM

MDR report key: 3243943 · Received July 23, 2013

Report

Report Number
2031527-2013-00169
Event Type
Death
Date Received
July 23, 2013
Date of Event
March 14, 2015
Report Date
February 22, 2015
Manufacturer
ENDOLOGIX, INC.
Product Code
MIH
PMA / PMN Number
P040002
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 1

ENDOLOGIX CONTINUES TO INVESTIGATE THE REPORTED EVENT. ENDOLOGIX WILL SUBMIT A SUPPLEMENTAL REPORT IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL INFORMATION BECOMES AVAILABLE. DEVICE REMAINS IMPLANTED IN THE PATIENT.

Description of Event or Problem · 1

IT WAS REPORTED THAT APPROXIMATELY 23 MONTHS POST-IMPLANT OF A BIFURCATED DEVICE, A SUPRARENAL AORTIC EXTENSION, AND THREE LIMB EXTENSIONS THE PATIENT PRESENTED WITH ABDOMINAL AND BACK PAIN. A COMPUTED TOMOGRAPHY SCAN REVEALED A TYPE III ENDOLEAK OF A BIFURCATED DEVICE. REPORTEDLY, THE PHYSICIAN IDENTIFIED A TYPE III ENDOLEAK BETWEEN THE SUPRARENAL AORTIC EXTENSION AND THE BIFURCATED DEVICE DURING A FOLLOW-UP COMPUTED TOMOGRAPHY SCAN (APPROXIMATELY 13 MONTHS), WHICH WAS ORIGINALLY TREATED WITH AN INFRARENAL AORTIC EXTENSION AND AN ADDITIONAL SUPRARENAL AORTIC EXTENSION. HOWEVER, APPROXIMATELY 10 MONTHS LATER, A FOLLOW-UP COMPUTED TOMOGRAPHY SCAN IDENTIFIED A TYPE III ENDOLEAK OF THE BIFURCATED DEVICE. THE PATIENT WAS TREATED WITH AN ADDITIONAL BIFURCATED DEVICE, WHICH SUCCESSFULLY CORRECTED THE ENDOLEAK. THE PATIENT TOLERATED THE PROCEDURE WELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
342635 AFX SYSTEM SUPRARENAL PROXIMAL EXTENSION STENT GRAFT MIH ENDOLOGIX, INC. A34-34/C100-O20 1044103-010

Patients

Seq Age Sex Outcome Treatment
1 86 YR Male Required Intervention| D